je.st
news
Valeant reports stronger Q1 results, issues bullish outlook for Q2 and 2015
2015-04-29 20:49:15| Biotech - Topix.net
Valeant Pharmaceuticals International Inc. has issued first quarter results that beat analyst estimates and boosted its 2015 estimates to account for about US$1 billion of additional revenue from Salix Pharmaceuticals. The Quebec-based company conducted a bidding war for Salix during the first quarter and closed the US$11.1-billion deal on April 1, which marked the beginning of its second quarter.
Tags: results
issues
reports
outlook
Category:Biotechnology and Pharmaceuticals